Risk factors and clinical manifestations in patients with pulmonary infections caused by nontuberculous mycobacteria.

Authors

  • Alina MALIC Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova
  • Adriana NIGULEANU Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova
  • Tatiana OSIPOV Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova
  • Vasile POPA Municipal Clinical Hospital of Phthisiopneumology

DOI:

https://doi.org/10.52692/1857-0011.2025.3-83.11

Keywords:

mycobacteriosis, MAC, M. kansasii, COPD

Abstract

The incidence of pulmonary infection with NTM increases with age and varies significantly between countries. NTMs are opportunistic pathogens that cause disease, especially in immunocompromised patients or with pre-existing lung disease. In 2021-2024, 22 patients with pulmonary mycobacteriosis were admitted to the MCHP. The majority of patients were men, MAC predominated, followed by M. kansasii. Risk factors included the medical-biological, HIV- infection, respiratory system pathology, harmful habits, hystory of tuberculosis (TB). Age over 51 years old had 50% of the patients. History of TB had 1/3 of the patients. Among the associated diseases the respiratory system diseases predominated (86,4%): COPD, bronchiectasis, neoplastic processes, othres. Diagnosis was estableshed in the period up 2 weeeks from hospitalisation in 68,8% cases. Clinical picture were presented by bronchopulmonary, toxico-infection syndromes.

Author Biographies

Alina MALIC, Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova

Doctor of Medical Sciences

Adriana NIGULEANU, Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova

dr. în șt. med

Tatiana OSIPOV, Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova

University Assistant

Vasile POPA, Municipal Clinical Hospital of Phthisiopneumology

Doctor of Medical Sciences

References

Babalik A, Koç EN, Sekerbey HG, et al. Nontuberculous mycobacteria isolation from sputum specimens: A retrospective analysis of 1061 cases. Int J Mycobacteriol. 2023;12(1):55-65.

Dhasmana DJ, Whitaker P, et al. A practical guide to the diagnosis and management of suspected Non- tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom. NPJ Prim Care Respir Med. 2024 21;34(1):45.

Ratnatunga CN, Lutzky VP, Kupz A, et al. The Rise of Non-Tuberculosis Mycobacterial Lung Disease. Front Immunol. 2020, 3;11:303.

Thornton, C. S., Mellett, M., Jarand, et al. The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health. Eur. Respir. Rev. 2020, 30 (160), 200299.

Wang DM, Liu H, et al. Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022. Front Cell Infect Microbiol. 2023, 31;13:1282902.

Weng YW, Huang CK, Sy CL, et al. Treatment for Mycobacterium abscessus complex-lung disease. J Formos Med Assoc. 2020;119 Suppl 1:S58-S66.

Zhou, L., Xu, D., et al. Trends in the prevalence and antibiotic resistance of non-tuberculous mycobacteria in mainland China, 2000-2019: systematic review and meta-analysis. Front. Public Health. 2020, 8: 295.

Published

2026-04-29

Issue

Section

Research Article

Categories